Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment

A novel anti-leukemia compound with little toxicity successfully treated zebrafish with T-cell acute lymphoblastic leukemia (T-ALL), suggesting its potential to become a new highly targeted therapy for humans -- even those resistant to conventional therapies -- according to new results.

Read the whole article on Science Daily

More from Science Daily